Fragrance pump business sold
This article was originally published in The Rose Sheet
Executive Summary
Crown Cork & Seal signed agreement to sell Thomaston, Conn.-based fragrance pump manufacturing business to Rexam for approximately $107 mil., packaging supplier announces. Proceeds from sale will be used to reduce outstanding short-term debt. Primary products manufactured at the plant are fine mist spray actuated pumps used in personal fragrance applications, company notes. Crown Cork & Seal will continue to manufacture molded and assembled plastic and metal packaging for lipstick, lip gloss, mascara, compacts and fragrance caps, company adds. For London-based Rexam, agreement is in line with consumer products packaging company's strategic focus on beauty, healthcare, beverage and food industries...
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.